Literature DB >> 19683939

Antimony(III)-D, L-tartrates exhibit proton-assisted enantioselective binding in solution and in the gas phase.

Aruna B Wijeratne1, Sandra E Spencer, Jose Gracia, Daniel W Armstrong, Kevin A Schug.   

Abstract

The negative ion mode ESI mass spectral analysis of antimony(III)-D- and -L-tartrate ("tartar emetic"), in association with leucine enantiomeric isotopomers, revealed remarkable proton-assisted enantioselective molecular recognition phenomena. The current study infers that recognition of amino acids by antimony(III)-D,L-tartrate complexes requires that the chiral selector associate a proton to become enantioselective. The dianionic selector itself failed to show enantiomeric discrimination capacity. This observation was shown to be consistent both in solution-phase targeting full scan and gas-phase targeting collision threshold dissociation (CTD) experiments. Importantly, this disparity in enantioselective binding capacity between the dianionic and the protonated monoanionic representatives of antimony(III)-D- and -L-tartrates could only be clearly revealed by ESI-MS and tandem mass spectrometry experiments as described herein. This finding urges a more in-depth study of mechanisms associated with exhibited enantiomeric resolving capacity of antimony tartrates in HPLC and CE applications, as well as in former ESI-MS association studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683939     DOI: 10.1016/j.jasms.2009.07.011

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  20 in total

1.  Deuterium isotope effects observed during competitive binding chiral recognition electrospray ionization--mass spectrometry of cinchona alkaloid-based systems.

Authors:  Kevin A Schug; Norbert M Maier; Wolfgang Lindner
Journal:  J Mass Spectrom       Date:  2006-02       Impact factor: 1.982

Review 2.  Advances in drug discovery and biochemical studies.

Authors:  Kiyoshi Kita; Kazuro Shiomi; Satoshi Omura
Journal:  Trends Parasitol       Date:  2007-03-23

Review 3.  Analysis of protein complexes using mass spectrometry.

Authors:  Anne-Claude Gingras; Matthias Gstaiger; Brian Raught; Ruedi Aebersold
Journal:  Nat Rev Mol Cell Biol       Date:  2007-08       Impact factor: 94.444

4.  "Anti-moine; anti-biotique": the public fortunes of the secret properties of antimony potassium tartrate (tartar emetic).

Authors:  J Duffin; P René
Journal:  J Hist Med Allied Sci       Date:  1991-10       Impact factor: 2.088

Review 5.  Molecular recognition properties of tartrates and metal-tartrates in solution and gas phase.

Authors:  Aruna B Wijeratne; Kevin A Schug
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

6.  Gas-phase stability of double-stranded oligodeoxynucleotides and their noncovalent complexes with DNA-binding drugs as revealed by collisional activation in an ion trap.

Authors:  K X Wan; M L Gross; T Shibue
Journal:  J Am Soc Mass Spectrom       Date:  2000-05       Impact factor: 3.109

7.  Does electrospray ionization produce gas-phase or liquid-phase structures?

Authors:  Zhixin Tian; Steven R Kass
Journal:  J Am Chem Soc       Date:  2008-07-29       Impact factor: 15.419

8.  Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.

Authors:  Kevin A Schug; Manishkumar D Joshi; Petr Frycák; Norbert M Maier; Wolfgang Lindner
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-17       Impact factor: 3.109

9.  Favorable effects of weak acids on negative-ion electrospray ionization mass spectrometry.

Authors:  Zengru Wu; Wenqing Gao; Mitch A Phelps; Di Wu; Duane D Miller; James T Dalton
Journal:  Anal Chem       Date:  2004-02-01       Impact factor: 6.986

10.  Enantioselective recognition of alanine in solution with modified gold electrodes using chiral PAMAM dendrimers G4.0.

Authors:  E Bustos; J E García; Y Bandala; Luis A Godínez; E Juaristi
Journal:  Talanta       Date:  2009-02-20       Impact factor: 6.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.